These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28802779)

  • 21. Advances toward the implantable artificial pancreas for treatment of diabetes.
    Jaremko J; Rorstad O
    Diabetes Care; 1998 Mar; 21(3):444-50. PubMed ID: 9540030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin pumps: closer to a pancreas.
    Tucker SE
    Diabetes Forecast; 2015; 68(2):58-63. PubMed ID: 25812187
    [No Abstract]   [Full Text] [Related]  

  • 25. Closing the Loop.
    Nimri R; Audon P; Pinsker JE; Dassau E
    Diabetes Technol Ther; 2018 Feb; 20(S1):S41-S54. PubMed ID: 29437478
    [No Abstract]   [Full Text] [Related]  

  • 26. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 27. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of glucose-responsive 'smart' insulin systems.
    Rege NK; Phillips NFB; Weiss MA
    Curr Opin Endocrinol Diabetes Obes; 2017 Aug; 24(4):267-278. PubMed ID: 28509691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin patch pumps: their development and future in closed-loop systems.
    Anhalt H; Bohannon NJ
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1(Suppl 1):S51-8. PubMed ID: 20515308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Technologies for the Management of Type 1 Diabetes in Pregnancy.
    Yamamoto JM; Murphy HR
    Curr Diab Rep; 2018 Jan; 18(1):4. PubMed ID: 29383544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A New Optimized Percutaneous Access System for CIPII.
    Garcia-Verdugo R; Erbach M; Schnell O
    J Diabetes Sci Technol; 2017 Jul; 11(4):814-821. PubMed ID: 28654300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes.
    Zaharieva DP; Messer LH; Paldus B; O'Neal DN; Maahs DM; Riddell MC
    Can J Diabetes; 2020 Dec; 44(8):740-749. PubMed ID: 33011134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas.
    Ang KH; Tamborlane WV; Weinzimer SA
    Expert Opin Drug Deliv; 2015; 12(10):1579-82. PubMed ID: 26389567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
    Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
    Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closed-loop artificial pancreas: current studies and promise for the future.
    Weinzimer SA
    Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):88-92. PubMed ID: 22327368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward Automation of Insulin Delivery - Management Solutions for Type 1 Diabetes.
    Nimri R; Phillip M
    Endocr Dev; 2016; 30():1-13. PubMed ID: 26682752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Insulin pump regulated by a glucose sensor; one step closer to closing the loop for type 1 diabetes patients].
    de Valk HW
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.